291 related articles for article (PubMed ID: 9160882)
1. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.
Watanabe Y; Lee SW; Detmar M; Ajioka I; Dvorak HF
Oncogene; 1997 May; 14(17):2025-32. PubMed ID: 9160882
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis.
Vasile E; Tomita Y; Brown LF; Kocher O; Dvorak HF
FASEB J; 2001 Feb; 15(2):458-66. PubMed ID: 11156961
[TBL] [Abstract][Full Text] [Related]
3. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
4. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation.
Watanabe Y; Dvorak HF
Exp Cell Res; 1997 Jun; 233(2):340-9. PubMed ID: 9194496
[TBL] [Abstract][Full Text] [Related]
5. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM
Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172
[TBL] [Abstract][Full Text] [Related]
6. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.
Rak J; Mitsuhashi Y; Bayko L; Filmus J; Shirasawa S; Sasazuki T; Kerbel RS
Cancer Res; 1995 Oct; 55(20):4575-80. PubMed ID: 7553632
[TBL] [Abstract][Full Text] [Related]
7. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
Pal S; Datta K; Mukhopadhyay D
Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
Sioussat TM; Dvorak HF; Brock TA; Senger DR
Arch Biochem Biophys; 1993 Feb; 301(1):15-20. PubMed ID: 8442657
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade.
Pal S; Iruela-Arispe ML; Harvey VS; Zeng H; Nagy JA; Dvorak HF; Mukhopadhyay D
Microvasc Res; 2000 Sep; 60(2):112-20. PubMed ID: 10964585
[TBL] [Abstract][Full Text] [Related]
10. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells.
Richard L; Velasco P; Detmar M
Exp Cell Res; 1998 Apr; 240(1):1-6. PubMed ID: 9570915
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of telomerase in endothelial cells by fibroblast growth factor-2 and vascular endothelial growth factor-a: association with replicative life span.
Trivier E; Kurz DJ; Hong Y; Huang HL; Erusalimsky JD
Ann N Y Acad Sci; 2004 Jun; 1019():111-5. PubMed ID: 15247002
[TBL] [Abstract][Full Text] [Related]
12. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.
Kondo S; Asano M; Suzuki H
Biochem Biophys Res Commun; 1993 Aug; 194(3):1234-41. PubMed ID: 7688963
[TBL] [Abstract][Full Text] [Related]
13. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells.
Detmar M; Yeo KT; Nagy JA; Van de Water L; Brown LF; Berse B; Elicker BM; Ledbetter S; Dvorak HF
J Invest Dermatol; 1995 Jul; 105(1):44-50. PubMed ID: 7615975
[TBL] [Abstract][Full Text] [Related]
14. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.
Basu S; Nagy JA; Pal S; Vasile E; Eckelhoefer IA; Bliss VS; Manseau EJ; Dasgupta PS; Dvorak HF; Mukhopadhyay D
Nat Med; 2001 May; 7(5):569-74. PubMed ID: 11329058
[TBL] [Abstract][Full Text] [Related]
15. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
16. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors.
Iruela-Arispe ML; Rodriguez-Manzaneque JC; Abu-Jawdeh G
Microcirculation; 1999 Jun; 6(2):127-40. PubMed ID: 10466115
[TBL] [Abstract][Full Text] [Related]
17. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
Kranz A; Mayr U; Frank H; Waltenberger J
Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036
[TBL] [Abstract][Full Text] [Related]
18. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO
Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
Heiss JD; Papavassiliou E; Merrill MJ; Nieman L; Knightly JJ; Walbridge S; Edwards NA; Oldfield EH
J Clin Invest; 1996 Sep; 98(6):1400-8. PubMed ID: 8823305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
